We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$5.2B
AUM Growth
+$223M
Cap. Flow
+$501M
Cap. Flow %
9.63%
Top 10 Hldgs %
30.56%
Holding
1,228
New
36
Increased
827
Reduced
326
Closed
36
Avg Time Held
7.5 quarters
Top 10 Avg Time Held
7.1 quarters
Top 20 Avg Time Held
5.9 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$30.8M
2
MSFT icon
Microsoft
MSFT
+$27.5M
3
AMZN icon
Amazon
AMZN
+$16.1M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$12.9M
5
TSLA icon
Tesla
TSLA
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 13.99%
3 Consumer Discretionary 13.11%
4 Financials 11.18%
5 Industrials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SCHW icon
51
Charles Schwab
SCHW
$166B
$17.9M 0.34%
249,315
+24,429
+11% +$1.7M
2020 Q2
9 quarters
CSCO icon
52
Cisco
CSCO
$454B
$17.9M 0.34%
447,570
+55,755
+14% +$2.47M
2020 Q2
9 quarters
LIN icon
53
Linde
LIN
$227B
$17.6M 0.34%
65,465
+7,284
+13% +$2.09M
2020 Q2
9 quarters
IBM icon
54
IBM
IBM
$217B
$17.6M 0.34%
148,213
+15,686
+12% +$2.06M
2020 Q2
9 quarters
NEE icon
55
NextEra Energy
NEE
$163B
$15.9M 0.31%
203,185
+22,800
+13% +$1.93M
2020 Q2
9 quarters
ELV icon
56
Elevance Health
ELV
$92.2B
$15.8M 0.3%
34,880
+3,844
+12% +$1.84M
2020 Q2
9 quarters
ORCL icon
57
Oracle
ORCL
$434B
$15.8M 0.3%
258,409
+17,439
+7% +$1.28M
2020 Q2
9 quarters
CAT icon
58
Caterpillar
CAT
$355B
$15.7M 0.3%
95,825
+913
+1% +$167K
2020 Q2
9 quarters
BMY icon
59
Bristol-Myers Squibb
BMY
$116B
$15.6M 0.3%
219,534
+47,993
+28% +$3.48M
2020 Q2
9 quarters
NOW icon
60
ServiceNow
NOW
$143B
$15.5M 0.3%
205,350
+15,245
+8% +$1.37M
2020 Q2
9 quarters
NFLX icon
61
Netflix
NFLX
$293B
$15.3M 0.29%
650,900
+59,340
+10% +$1.32M
2020 Q2
9 quarters
AMAT icon
62
Applied Materials
AMAT
$368B
$14.8M 0.29%
181,225
+9,895
+6% +$954K
2020 Q2
9 quarters
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$123B
$14.8M 0.29%
51,270
+3,772
+8% +$1.09M
2020 Q2
9 quarters
COP icon
64
ConocoPhillips
COP
$169B
$14.4M 0.28%
140,228
+19,062
+16% +$1.9M
2020 Q2
9 quarters
WFC icon
65
Wells Fargo
WFC
$244B
$14.3M 0.28%
356,739
+61,941
+21% +$2.66M
2020 Q2
9 quarters
TJX icon
66
TJX Companies
TJX
$156B
$14.3M 0.28%
230,893
+19,580
+9% +$1.23M
2020 Q2
9 quarters
PYPL icon
67
PayPal
PYPL
$48.1B
$14.2M 0.27%
165,364
+29,684
+22% +$2.63M
2020 Q2
9 quarters
ZTS icon
68
Zoetis
ZTS
$30.7B
$14M 0.27%
94,473
-663
-0.7% -$111K
2020 Q2
9 quarters
HON icon
69
Honeywell
HON
$65.7B
$13.9M 0.27%
88,102
+10,910
+14% +$1.9M
2020 Q2
9 quarters
ISRG icon
70
Intuitive Surgical
ISRG
$149B
$13.8M 0.27%
73,674
+1,818
+3% +$390K
2020 Q2
9 quarters
MRSH icon
71
Marsh
MRSH
$84.5B
$13.8M 0.27%
92,450
+7,366
+9% +$1.18M
2020 Q2
9 quarters
BKNG icon
72
Booking.com
BKNG
$118B
$13.8M 0.27%
209,925
+13,325
+7% +$1M
2020 Q2
9 quarters
CMCSA icon
73
Comcast
CMCSA
$74.1B
$13.7M 0.26%
466,287
+68,691
+17% +$2.57M
2020 Q2
9 quarters
CVS icon
74
CVS Health
CVS
$112B
$13.6M 0.26%
142,368
+22,203
+18% +$2.2M
2020 Q2
9 quarters
PGR icon
75
Progressive
PGR
$129B
$12.9M 0.25%
111,214
+9,942
+10% +$1.2M
2020 Q2
9 quarters

Similar funds

Xponance's Q3 2022 Portfolio in Review

As of Q3 2022, Xponance held 1,228 positions worth $5.2B, up 4.5% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance deployed $501M of net new capital in Q3 2022, opening 36 new positions and adding to 827 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinnacle West Capital, an estimated $2.46M trimmed.

  • Xponance's largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 27,780 shares worth $1.22M.
  • Xponance added most to Apple in Q3 2022, an estimated $30.8M increase.
  • Xponance's biggest Q3 2022 reduction was Pinnacle West Capital, cutting an estimated $2.46M.
  • Xponance fully exited Atlassian in Q3 2022, selling an estimated $2.99M.
  • Xponance's ten largest holdings make up 31% of its $5.2B portfolio in Q3 2022.
  • Xponance opened 36 new positions and closed 36 in Q3 2022.
  • Xponance's portfolio value rose 4.5% quarter-over-quarter to $5.2B.

Based on Xponance's 13F filing for Q3 2022, filed 24 Oct 2022.